As of Mar 25
| -0.19 / -1.33%|
The 5 analysts offering 12-month price forecasts for Coherus BioSciences Inc have a median target of 25.00, with a high estimate of 35.00 and a low estimate of 22.00. The median estimate represents a +76.93% increase from the last price of 14.13.
The current consensus among 5 polled investment analysts is to Buy stock in Coherus BioSciences Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.